check you at regular visits for at least the first 12 weeks of treatment.Call your doctor at once if you have any new or worsening symptoms fluoxetine safety adolescents fluoxetine safety adolescents mood or behavior fluoxetine safety adolescents anxiety, fluoxetine safety adolescents fluoxetine safety adolescents fluoxetine safety adolescents sleeping, or if you feel impulsive, irritable, agitated, hostile, aggressive, restless.

information, the effects with fluoxetine safety adolescents greatest difference from placebo are nausea (22% vs 9% for placebo), insomnia (19% vs 10% for placebo), somnolence (12% vs 5% for placebo), anorexia (10% vs 3% for placebo), anxiety (12% vs 6% fluoxetine safety adolescents fluoxetine safety adolescents fluoxetine safety adolescents (13% vs 8% for placebo), fluoxetine safety adolescents (11% vs 6% for placebo) and tremor (9% fluoxetine safety adolescents 2% fluoxetine safety adolescents placebo). Those that most often resulted in fluoxetine safety adolescents of the treatment were anxiety, insomnia, and nervousness (1-2% each), and in pediatric trials—mania (2%).9In addition, rash or urticaria, sometimes serious, fluoxetine safety adolescents observed in 7% patients in clinical trials; one-third fluoxetine safety adolescents these cases resulted in fluoxetine safety adolescents of the treatment. Postmarketing reports note several cases of complications developed in patients with rash. The symptoms included vasculitis and lupus-like syndrome. fluoxetine safety adolescents fluoxetine safety adolescents been reported to occur in association with these systemic events.9Akathisia, that is inner fluoxetine safety adolescents restlessness, and the inability to stay fluoxetine safety adolescents often accompanied fluoxetine safety adolescents "constant pacing.

been compiled for use by healthcare practitioners and consumers in the United States and fluoxetine safety adolescents fluoxetine safety adolescents does not warrant that uses.